Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation

Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the ant...

Full description

Saved in:
Bibliographic Details
Published inToxicology (Amsterdam) Vol. 330; pp. 55 - 61
Main Authors Chen, Yi-Tzai, Trzoss, Lynnie, Yang, Dongfang, Yan, Bingfang
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 01.04.2015
Elsevier Ireland Ltd
Subjects
Online AccessGet full text
ISSN0300-483X
1879-3185
1879-3185
DOI10.1016/j.tox.2015.02.007

Cover

Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.
AbstractList Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.
Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1–198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.
Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1-198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative biotransformation, respectively. They share substrates but may have opposite effect on therapeutic potential such as the metabolism of the anticancer prodrug irinotecan. Both CES2 and CYP3A4 are expressed in the liver and the gastrointestinal tract. This study was conducted to determine whether CES2 and CYP3A4 are expressed under developmental regulation and whether the regulation occurs differentially between the liver and duodenum. A large number of tissues (112) were collected with majority of them from donors at 1-198 days of age. In addition, multi-sampling (liver, duodenum and jejunum) was performed in some donors. The expression was determined at mRNA and protein levels. In the liver, CES2 and CYP3A4 mRNA exhibited a postnatal surge (1 versus 2 months of age) by 2.7 and 29 fold, respectively. CYP3A4 but not CES2 mRNA in certain pediatric groups reached or even exceeded the adult level. The duodenal samples, on the other hand, showed a gene-specific expression pattern at mRNA level. CES2 mRNA increased with age but the opposite was true with CYP3A4 mRNA. The levels of CES2 and CYP3A4 protein, on the other hand, increased with age in both liver and duodenum. The multi-sampling study demonstrated significant correlation of CES2 expression between the duodenum and jejunum. However, neither duodenal nor jejunal expression correlated with hepatic expression of CES2. These findings establish that developmental regulation occurs in a gene and organ-dependent manner.
Author Chen, Yi-Tzai
Trzoss, Lynnie
Yan, Bingfang
Yang, Dongfang
Author_xml – sequence: 1
  givenname: Yi-Tzai
  surname: Chen
  fullname: Chen, Yi-Tzai
– sequence: 2
  givenname: Lynnie
  surname: Trzoss
  fullname: Trzoss, Lynnie
– sequence: 3
  givenname: Dongfang
  surname: Yang
  fullname: Yang, Dongfang
– sequence: 4
  givenname: Bingfang
  surname: Yan
  fullname: Yan, Bingfang
  email: byan@uri.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25724353$$D View this record in MEDLINE/PubMed
BookMark eNqNkk9rFDEYhwep2G31A3iRHL3Mmn-TmVEQSqlVKLSggreQSd7ZZp1J1iRTdr-En7nZ3fZSsOsphzy_N-T9PSfFkfMOiuItwXOCifiwnCe_nlNMqjmmc4zrF8WMNHVbMtJUR8UMM4xL3rBfx8VJjEuMMWVcvCqOaVVTzio2K_5eu-QX4KxGsF4FiNF6h3yPbqdROaRV6Px6M0BMEFSEkiLlDNKb5PVt8COgG15hxM44sg4N9g7CDjCTN-Cm8SO68TE5ldSA4hQWsLv1YaFcaWAFLlMJBVhMg0r55dfFy14NEd48nKfFzy8XP86_llfXl9_Oz65KLYRIOUpYJXrCOFa0x8bURvRMdQR3VOFWtbTqSM06zRmnHVNAGl33rDNtR0kFNTst3u_nroL_M-XfydFGDcOgHPgpStJwwQgReXkH0brGjNSt4P-BMtowiik9jArBSUuxEBl994BO3QhGroIdVdjIxxIzUO8BHXyMAXqpbdqtMwVlB0mw3OoilzLrIre6SExl1iUnyZPk4_DnMp_2Gcj93FkIMmoLToOxAXSSxttn05-fpPVgs31q-A0biEs_BZeLl0TGHJDftwpvDSZVtpezbR3tvwccePweWDoABg
CitedBy_id crossref_primary_10_1002_hep_31250
crossref_primary_10_1016_j_bmc_2024_117938
crossref_primary_10_1007_s00280_017_3447_x
crossref_primary_10_1111_fcp_12889
crossref_primary_10_1093_toxsci_kfz237
crossref_primary_10_1124_dmd_118_084418
crossref_primary_10_3390_pharmaceutics15092231
crossref_primary_10_2903_j_efsa_2020_6153
crossref_primary_10_1124_dmd_116_072652
crossref_primary_10_1124_dmd_121_000559
crossref_primary_10_1016_j_addr_2021_03_011
crossref_primary_10_1016_j_ejpb_2023_08_011
crossref_primary_10_1124_dmd_115_068957
crossref_primary_10_1002_bdd_2052
crossref_primary_10_1080_17425255_2024_2348491
crossref_primary_10_2174_1389200224666221212143904
crossref_primary_10_1002_cpt_3354
crossref_primary_10_2174_1389200219666180821094502
crossref_primary_10_1248_bpb_b17_00880
crossref_primary_10_3390_pharmaceutics13060887
crossref_primary_10_1111_bcp_14111
crossref_primary_10_3390_pharmaceutics15112579
crossref_primary_10_1016_j_apsb_2016_07_012
crossref_primary_10_1111_epi_16746
crossref_primary_10_1016_j_canlet_2016_04_041
crossref_primary_10_1002_jcph_1284
crossref_primary_10_1016_j_ijpharm_2024_123962
crossref_primary_10_3390_pharmaceutics15122765
crossref_primary_10_1016_j_ntt_2021_106983
crossref_primary_10_1002_psp4_13192
crossref_primary_10_1177_1091581817721675
crossref_primary_10_1248_yakushi_18_00228
Cites_doi 10.1634/theoncologist.2010-0260
10.2174/0929867033456855
10.1186/1472-6939-14-55
10.3389/fgene.2013.00012
10.1006/taap.1999.8693
10.1124/dmd.112.050211
10.1016/S0021-9258(18)43935-X
10.1002/jcph.161
10.1074/jbc.M709382200
10.3109/00498254.2012.694493
10.1124/dmd.109.028209
10.2174/092986609789071324
10.1124/dmd.105.007807
10.1016/j.bcp.2008.10.005
10.1124/jpet.104.074971
10.1124/dmd.113.054635
10.1124/dmd.105.005611
10.1006/abbi.1995.1121
10.1006/abbi.1994.1532
10.1006/taap.1994.1106
10.1124/dmd.105.008672
10.1124/mol.107.036889
10.2337/diab.46.8.1319
10.1093/infdis/jiq145
10.1016/S0090-9556(25)08432-6
10.1016/j.bbalip.2007.01.007
10.1016/j.ijpharm.2012.05.079
10.1016/j.bcp.2012.04.002
10.1124/dmd.30.5.541
10.1016/S0300-483X(01)00416-4
10.1371/journal.pone.0082562
10.1016/j.tiv.2005.06.045
10.1042/BJ20070613
10.1002/med.20014
10.1111/j.1740-8261.2009.01626.x
10.1038/clpt.2013.220
10.1016/j.cmet.2010.02.001
10.1016/S0090-9556(24)15127-6
10.1124/dmd.110.035956
10.1124/dmd.109.027680
ContentType Journal Article
Copyright 2015 Elsevier Ireland Ltd
Elsevier Ireland Ltd
2015
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Copyright_xml – notice: 2015 Elsevier Ireland Ltd
– notice: Elsevier Ireland Ltd
– notice: 2015
– notice: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U7
C1K
8FD
FR3
KR7
7S9
L.6
DOI 10.1016/j.tox.2015.02.007
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Toxicology Abstracts
Environmental Sciences and Pollution Management
Technology Research Database
Engineering Research Database
Civil Engineering Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Toxicology Abstracts
Environmental Sciences and Pollution Management
Technology Research Database
Civil Engineering Abstracts
Engineering Research Database
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA



MEDLINE - Academic
MEDLINE
Technology Research Database
Toxicology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-3185
EndPage 61
ExternalDocumentID 25724353
10_1016_j_tox_2015_02_007
S0300483X15000438
1_s2_0_S0300483X15000438
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: GM61988
– fundername: NIEHS NIH HHS
  grantid: R29 ES007965
– fundername: NCCIH NIH HHS
  grantid: R15 AT007705
– fundername: NIEHS NIH HHS
  grantid: ES07965
– fundername: NIGMS NIH HHS
  grantid: R01 GM061988
– fundername: NIEHS NIH HHS
  grantid: R01 ES007965
– fundername: NCCIH NIH HHS
  grantid: AT007705
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABFRF
ABFYP
ABJNI
ABLST
ABMAC
ABOCM
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHEUO
AIEXJ
AIIUN
AIKHN
AITUG
AJUYK
AKBMS
AKIFW
AKRWK
AKYEP
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
AXJTR
BKOJK
BLECG
BLXMC
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KCYFY
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OB~
OGGZJ
OM0
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSJ
SSP
SSZ
T5K
WH7
Z5R
~G-
.GJ
29Q
3O-
53G
AACTN
AAQXK
ABEFU
ABFNM
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFCTW
AFFNX
AFJKZ
AFKWA
AHHHB
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
R2-
SEW
SPT
WUQ
XPP
Y6R
ZGI
ZXP
AAIAV
AATCM
ABYKQ
AJBFU
EFLBG
AAYXX
AGQPQ
AIGII
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
SSH
7X8
7U7
C1K
8FD
FR3
KR7
7S9
L.6
ID FETCH-LOGICAL-c666t-de1356f1340a2f0dd7d6f3ab10b2a09a925b173bc4342b3ae18c7f3bd9b215e73
IEDL.DBID AIKHN
ISSN 0300-483X
1879-3185
IngestDate Thu Sep 04 18:05:33 EDT 2025
Thu Sep 04 18:57:15 EDT 2025
Thu Sep 04 20:56:15 EDT 2025
Fri Sep 05 06:59:50 EDT 2025
Thu Apr 03 07:08:23 EDT 2025
Thu Apr 24 22:53:48 EDT 2025
Wed Sep 10 05:18:23 EDT 2025
Fri Feb 23 02:25:34 EST 2024
Sun Feb 23 10:19:01 EST 2025
Tue Aug 26 16:33:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords PBS
GI
Toxicology
Cytochrome P450
Drug metabolism
Ontogeny
CYP3A4
PPARα
GAPDH
RT-qPCR
CES2
Carboxylesterases
reverse transcription-quantitative polymerase chain reaction
carboxylesterase-2
peroxisome proliferator-activated receptor-α
cytochrome P450 3A4
gastrointestinal
phosphate buffered saline
glyceradehyde-3-phosphate dehydrogenase
Language English
License Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c666t-de1356f1340a2f0dd7d6f3ab10b2a09a925b173bc4342b3ae18c7f3bd9b215e73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/4496585
PMID 25724353
PQID 1664192066
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1846311648
proquest_miscellaneous_1770317964
proquest_miscellaneous_1732832022
proquest_miscellaneous_1664192066
pubmed_primary_25724353
crossref_citationtrail_10_1016_j_tox_2015_02_007
crossref_primary_10_1016_j_tox_2015_02_007
elsevier_sciencedirect_doi_10_1016_j_tox_2015_02_007
elsevier_clinicalkeyesjournals_1_s2_0_S0300483X15000438
elsevier_clinicalkey_doi_10_1016_j_tox_2015_02_007
PublicationCentury 2000
PublicationDate 2015-04-01
PublicationDateYYYYMMDD 2015-04-01
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Toxicology (Amsterdam)
PublicationTitleAlternate Toxicology
PublicationYear 2015
Publisher Elsevier B.V
Elsevier Ireland Ltd
Publisher_xml – name: Elsevier B.V
– name: Elsevier Ireland Ltd
References Takagi, Nakajima, Mohri, Yokoi (bib0150) 2008; 283
Liu, Olivier, Pope (bib0055) 1999; 158
Pearce, Gotschall, Kearns, Leeder (bib0090) 2001; 29
Zancanella, Giantin, Lopparelli, Nebbia, Dacasto (bib0200) 2012; 42
Sanghani, Sanghani, Schiel, Bosron (bib0110) 2009; 16
Hines (bib0030) 2013; 452
Schleidgen, Klingler, Bertram, Rogowski, Marckmann (bib0115) 2013; 14
Yan, Yang, Brady, Parkinson (bib0170) 1994; 269
Lewis (bib0050) 2003; 10
Deenen, Cats, Beijnen, Schellens (bib0015) 2011; 16
Xie, Yang, Liu, Xue, Yan (bib0165) 2002; 30
Morgan, Yan, Greenway, Parkinson (bib0070) 1994; 315
Hosokawa, Hirata, Nakata, Suga, Satoh (bib0040) 1994; 22
Yan (bib0180) 2012
Yang, Pearce, Wang, Roger, Wan, Yan (bib0190) 2009; 77
Fakhoury, Litalien, Medard, Cavé, Ezzahir, Peuchmaur, Jacqz-Aigrain (bib0020) 2005; 33
Patel, Parker, Yang, Zhang (bib0085) 2013; 10
Paine, Hart, Ludington, Haining, Rettie, Zeldin (bib0075) 2006; 34
Yang, Shi, Yang, Song, Yan (bib0185) 2007; 72
Poole, Bridgers, Alexson, Corton (bib0100) 2001; 165
Klein, Zanger (bib0045) 2013; 4
Shi, Yang, Prinssen, Davies, Yan (bib0125) 2011; 203
Preissner, Hoffmann, Preissner, Dunkel, Gewiess, Preissner (bib0105) 2013; 8
Yan, Yang, Brady, Parkinson (bib0175) 1995; 316
Liu, Yang, Song, Deng, Yan (bib0060) 2008; 409
Peng, Cui, Yoo, Gunewardena, Lu, Klaassen, Zhong (bib0095) 2013; 41
Wu, Yan, Humerickhouse, Dolan (bib0155) 2002; 8
Auboeuf, Rieusset, Fajas, Vallier, Frering, Riou, Staels, Auwerx, Laville, Vidal (bib0010) 1997; 46
Zhu, Song, Zhang, Matoney, LeCluyse, Yan (bib0210) 2000; 28
Hagihara, Kazui, Ikenaga, Nanba, Fusegawa, Izumi, Ikeda, Kurihara (bib0025) 2011; 39
You (bib0195) 2004; 24
Stander, Wagner, Goddard, Kirberger (bib0140) 2010; 51
Song, Li, Liu, Mukundan, Yan (bib0135) 2005; 312
Zoete, Grosdidier, Michielin (bib0220) 2007; 1771
Smith, Figg, Sparreboom (bib0130) 2006; 20
Stoll, Burhenne, Lausecker, Weiss, Thomsen, Haefeli, Mikus (bib0145) 2013; 53
Hondares, Rosell, Gonzalez, Giralt, Iglesias, Villarroya (bib0035) 2010; 11
Pan, Gao, Yu (bib0080) 2009; 37
Sheets, Doherty, Law, Reiter, Crofton (bib0120) 1994; 126
Zanger, Klein, Thomas, Rieger, Tremmel, Kandel, Klein, Magdy (bib0205) 2014; 95
Anand, Kim, Padilla, Muralidhara, Kim, Fisher, Bruckner (bib0005) 2006; 34
Zhu, Appel, Jiang, Markowitz (bib0215) 2009; 37
Lu, Gunewardena, Cui, Yoo, Zhong, Klaassen (bib0065) 2013; 41
Xiao, Chen, Yang, Yan (bib0160) 2012; 84
Zoete (10.1016/j.tox.2015.02.007_bib0220) 2007; 1771
Lu (10.1016/j.tox.2015.02.007_bib0065) 2013; 41
Xiao (10.1016/j.tox.2015.02.007_bib0160) 2012; 84
Zhu (10.1016/j.tox.2015.02.007_bib0210) 2000; 28
Pearce (10.1016/j.tox.2015.02.007_bib0090) 2001; 29
Yan (10.1016/j.tox.2015.02.007_bib0180) 2012
Stander (10.1016/j.tox.2015.02.007_bib0140) 2010; 51
Xie (10.1016/j.tox.2015.02.007_bib0165) 2002; 30
Zancanella (10.1016/j.tox.2015.02.007_bib0200) 2012; 42
Yang (10.1016/j.tox.2015.02.007_bib0185) 2007; 72
Zhu (10.1016/j.tox.2015.02.007_bib0215) 2009; 37
Deenen (10.1016/j.tox.2015.02.007_bib0015) 2011; 16
Takagi (10.1016/j.tox.2015.02.007_bib0150) 2008; 283
Pan (10.1016/j.tox.2015.02.007_bib0080) 2009; 37
Wu (10.1016/j.tox.2015.02.007_bib0155) 2002; 8
Poole (10.1016/j.tox.2015.02.007_bib0100) 2001; 165
You (10.1016/j.tox.2015.02.007_bib0195) 2004; 24
Stoll (10.1016/j.tox.2015.02.007_bib0145) 2013; 53
Paine (10.1016/j.tox.2015.02.007_bib0075) 2006; 34
Liu (10.1016/j.tox.2015.02.007_bib0055) 1999; 158
Hines (10.1016/j.tox.2015.02.007_bib0030) 2013; 452
Hosokawa (10.1016/j.tox.2015.02.007_bib0040) 1994; 22
Peng (10.1016/j.tox.2015.02.007_bib0095) 2013; 41
Song (10.1016/j.tox.2015.02.007_bib0135) 2005; 312
Smith (10.1016/j.tox.2015.02.007_bib0130) 2006; 20
Lewis (10.1016/j.tox.2015.02.007_bib0050) 2003; 10
Schleidgen (10.1016/j.tox.2015.02.007_bib0115) 2013; 14
Sanghani (10.1016/j.tox.2015.02.007_bib0110) 2009; 16
Patel (10.1016/j.tox.2015.02.007_bib0085) 2013; 10
Preissner (10.1016/j.tox.2015.02.007_bib0105) 2013; 8
Auboeuf (10.1016/j.tox.2015.02.007_bib0010) 1997; 46
Anand (10.1016/j.tox.2015.02.007_bib0005) 2006; 34
Yan (10.1016/j.tox.2015.02.007_bib0170) 1994; 269
Yang (10.1016/j.tox.2015.02.007_bib0190) 2009; 77
Sheets (10.1016/j.tox.2015.02.007_bib0120) 1994; 126
Liu (10.1016/j.tox.2015.02.007_bib0060) 2008; 409
Shi (10.1016/j.tox.2015.02.007_bib0125) 2011; 203
Yan (10.1016/j.tox.2015.02.007_bib0175) 1995; 316
Klein (10.1016/j.tox.2015.02.007_bib0045) 2013; 4
Zanger (10.1016/j.tox.2015.02.007_bib0205) 2014; 95
Fakhoury (10.1016/j.tox.2015.02.007_bib0020) 2005; 33
Morgan (10.1016/j.tox.2015.02.007_bib0070) 1994; 315
Hondares (10.1016/j.tox.2015.02.007_bib0035) 2010; 11
Hagihara (10.1016/j.tox.2015.02.007_bib0025) 2011; 39
12171903 - Clin Cancer Res. 2002 Aug;8(8):2696-700
23939663 - J Clin Pharmacol. 2013 Nov;53(11):1199-204
11950785 - Drug Metab Dispos. 2002 May;30(5):541-7
18983829 - Biochem Pharmacol. 2009 Jan 15;77(2):238-47
20166399 - Vet Radiol Ultrasound. 2010 Jan-Feb;51(1):75-8
15367577 - J Pharmacol Exp Ther. 2005 Feb;312(2):571-82
22766445 - Int J Pharm. 2013 Aug 16;452(1-2):3-7
9231657 - Diabetes. 1997 Aug;46(8):1319-27
11717173 - Drug Metab Dispos. 2001 Dec;29(12):1548-54
24340040 - PLoS One. 2013;8(12):e82562
7986099 - Arch Biochem Biophys. 1994 Dec;315(2):513-26
21189331 - Drug Metab Dispos. 2011 Apr;39(4):565-70
7961958 - J Biol Chem. 1994 Nov 25;269(47):29688-96
23382457 - Drug Metab Dispos. 2013 Apr;41(4):844-57
11522369 - Toxicology. 2001 Aug 28;165(2-3):109-19
20197053 - Cell Metab. 2010 Mar 3;11(3):206-12
18268015 - J Biol Chem. 2008 Apr 11;283(15):9674-80
15250040 - Med Res Rev. 2004 Nov;24(6):762-74
23444277 - Front Genet. 2013 Feb 25;4:12
21402544 - J Infect Dis. 2011 Apr 1;203(7):937-42
10406933 - Toxicol Appl Pharmacol. 1999 Jul 15;158(2):186-96
7864649 - Arch Biochem Biophys. 1995 Feb 1;316(2):899-908
24359531 - BMC Med Ethics. 2013;14:55
17537833 - Mol Pharmacol. 2007 Sep;72(3):686-94
17317294 - Biochim Biophys Acta. 2007 Aug;1771(8):915-25
16271446 - Toxicol In Vitro. 2006 Mar;20(2):163-75
24196843 - Clin Pharmacol Ther. 2014 Mar;95(3):258-61
16467132 - Drug Metab Dispos. 2006 May;34(5):880-6
1714639 - Toxicology. 1991;68(1):51-61
22513142 - Biochem Pharmacol. 2012 Jul 15;84(2):232-9
22694178 - Xenobiotica. 2012 Nov;42(11):1096-109
12871098 - Curr Med Chem. 2003 Oct;10(19):1955-72
16049125 - Drug Metab Dispos. 2005 Nov;33(11):1603-7
21659608 - Oncologist. 2011;16(7):992-1005
7895606 - Drug Metab Dispos. 1994 Nov-Dec;22(6):889-94
16326812 - Drug Metab Dispos. 2006 Mar;34(3):389-97
10640517 - Drug Metab Dispos. 2000 Feb;28(2):186-91
8184428 - Toxicol Appl Pharmacol. 1994 May;126(1):186-90
24080161 - Drug Metab Dispos. 2013 Dec;41(12):2175-86
19508181 - Protein Pept Lett. 2009;16(10):1207-14
19581388 - Drug Metab Dispos. 2009 Oct;37(10):2112-7
24349831 - Cancer Biol Med. 2013 Dec;10(4):214-20
19487248 - Drug Metab Dispos. 2009 Sep;37(9):1819-25
17764444 - Biochem J. 2008 Jan 1;409(1):243-50
References_xml – volume: 8
  start-page: e82562
  year: 2013
  ident: bib0105
  article-title: Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy
  publication-title: PLoS One
– volume: 33
  start-page: 1603
  year: 2005
  end-page: 1607
  ident: bib0020
  article-title: Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age
  publication-title: Drug Metab. Dispos.
– volume: 41
  start-page: 2175
  year: 2013
  end-page: 2186
  ident: bib0095
  article-title: RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice
  publication-title: Drug Metab. Dispos.
– volume: 51
  start-page: 75
  year: 2010
  end-page: 78
  ident: bib0140
  article-title: Normal canine pediatric gastrointestinal ultrasonography
  publication-title: Vet. Radiol. Ultrasound
– volume: 203
  start-page: 937
  year: 2011
  end-page: 942
  ident: bib0125
  article-title: Surge in expression of carboxylesterase-1 during the post-natal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir
  publication-title: J. Infect. Dis.
– volume: 77
  start-page: 238
  year: 2009
  end-page: 247
  ident: bib0190
  article-title: Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
  publication-title: Biochem. Pharmacol.
– volume: 28
  start-page: 186
  year: 2000
  end-page: 191
  ident: bib0210
  article-title: Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats
  publication-title: Drug Metab. Dispos.
– volume: 8
  start-page: 2696
  year: 2002
  end-page: 2700
  ident: bib0155
  article-title: Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells
  publication-title: Clin. Cancer Res.
– volume: 22
  start-page: 889
  year: 1994
  end-page: 894
  ident: bib0040
  article-title: Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl) phthalate a peroxisome proliferator
  publication-title: Drug Metab. Dispos.
– volume: 158
  start-page: 186
  year: 1999
  end-page: 196
  ident: bib0055
  article-title: Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 11
  start-page: 206
  year: 2010
  end-page: 212
  ident: bib0035
  article-title: Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat
  publication-title: Cell Metab.
– volume: 24
  start-page: 762
  year: 2004
  end-page: 774
  ident: bib0195
  article-title: Towards an understanding of organic anion transporters: structure-function relationships
  publication-title: Med. Res. Rev.
– volume: 37
  start-page: 2112
  year: 2009
  end-page: 2117
  ident: bib0080
  article-title: MicroRNAs regulate CYP3A4 expression via direct and indirect targeting
  publication-title: Drug Metab. Dispos.
– volume: 95
  start-page: 258
  year: 2014
  end-page: 261
  ident: bib0205
  article-title: Genetics: epigenetics and regulation of drug metabolizing cytochrome P450 enzymes
  publication-title: Clin. Pharmacol. Ther.
– volume: 34
  start-page: 389
  year: 2006
  end-page: 397
  ident: bib0005
  article-title: Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity
  publication-title: Drug Metab. Dispos.
– volume: 4
  start-page: 12
  year: 2013
  ident: bib0045
  article-title: Pharmacogenomics of cytochrome P450 3A4: recent progress toward the missing heritability problem
  publication-title: Front. Genet.
– volume: 14
  start-page: 55
  year: 2013
  ident: bib0115
  article-title: What is personalized medicine: sharpening a vague term based on a systematic literature review
  publication-title: BMC Med. Ethics
– volume: 315
  start-page: 514
  year: 1994
  end-page: 526
  ident: bib0070
  article-title: Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution and the effects of age sex and xenobiotic treatment of rats
  publication-title: Arch. Biochem. Biophys.
– volume: 39
  start-page: 565
  year: 2011
  end-page: 570
  ident: bib0025
  article-title: The intestine as an important contributor to prasugrel active metabolite formation in vivo
  publication-title: Drug Metab. Dispos.
– volume: 16
  start-page: 1207
  year: 2009
  end-page: 1214
  ident: bib0110
  article-title: Human carboxylesterases: an update on CES1, CES2 and CES3
  publication-title: Protein Pept. Lett.
– volume: 37
  start-page: 1819
  year: 2009
  end-page: 1825
  ident: bib0215
  article-title: Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver
  publication-title: Drug Metab. Dispos.
– volume: 41
  start-page: 844
  year: 2013
  end-page: 857
  ident: bib0065
  article-title: RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice
  publication-title: Drug Metab. Dispos.
– volume: 10
  start-page: 214
  year: 2013
  end-page: 220
  ident: bib0085
  article-title: Translational genomics in cancer research: converting profiles into personalized cancer medicine
  publication-title: Cancer Biol. Med.
– volume: 30
  start-page: 541
  year: 2002
  end-page: 547
  ident: bib0165
  article-title: Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression
  publication-title: Drug Metab. Dispos.
– volume: 53
  start-page: 1199
  year: 2013
  end-page: 1204
  ident: bib0145
  article-title: Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity
  publication-title: J. Clin. Pharmacol.
– volume: 72
  start-page: 686
  year: 2007
  end-page: 694
  ident: bib0185
  article-title: Interleukin-6 suppresses the expression of carboxylesterases HCE1 and HCE2 through transcriptional repression
  publication-title: Mol. Pharmacol.
– volume: 42
  start-page: 1096
  year: 2012
  end-page: 1109
  ident: bib0200
  article-title: Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues
  publication-title: Xenobiotica
– volume: 409
  start-page: 243
  year: 2008
  end-page: 250
  ident: bib0060
  article-title: The far and distal enhancers in the CYP3A4 gene coordinates the proximal promoter in responding to the pregnane X receptor similarly but differentially to hepatocyte nuclear factor-4α
  publication-title: Biochem. J.
– volume: 34
  start-page: 880
  year: 2006
  end-page: 886
  ident: bib0075
  article-title: The human intestinal cytochrome P450 pie
  publication-title: Drug Metab. Dispos.
– start-page: 165
  year: 2012
  end-page: 199
  ident: bib0180
  article-title: Hydrolytic enzymes
  publication-title: Metabolism of Drugs and Other Xenobiotics
– volume: 29
  start-page: 1548
  year: 2001
  end-page: 1554
  ident: bib0090
  article-title: Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms
  publication-title: Drug Metab. Dispos.
– volume: 10
  start-page: 1955
  year: 2003
  end-page: 1972
  ident: bib0050
  article-title: Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1 CYP2 and CYP3 families
  publication-title: Curr. Med. Chem.
– volume: 165
  start-page: 109
  year: 2001
  end-page: 119
  ident: bib0100
  article-title: Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals
  publication-title: Toxicology
– volume: 16
  start-page: 992
  year: 2011
  end-page: 1005
  ident: bib0015
  article-title: Part 3: pharmacogenetic variability in phase II anticancer drug metabolism
  publication-title: Oncologist
– volume: 1771
  start-page: 915
  year: 2007
  end-page: 925
  ident: bib0220
  article-title: Peroxisome proliferator-activated receptor structures: ligand specificity: molecular switch and interactions with regulators
  publication-title: Biochim. Biophys. Acta
– volume: 46
  start-page: 1319
  year: 1997
  end-page: 1327
  ident: bib0010
  article-title: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients
  publication-title: Diabetes
– volume: 126
  start-page: 186
  year: 1994
  end-page: 190
  ident: bib0120
  article-title: Age-dependent differences in the susceptibility of rats to deltamethrin
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 312
  start-page: 571
  year: 2005
  end-page: 582
  ident: bib0135
  article-title: Simultaneous substitution of phenylalaine-305 and aspartate-318 of rat PXR by the corresponding human residues abolishes the ability to transactivate the cytochrome P4503A23 promoter
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 316
  start-page: 899
  year: 1995
  end-page: 908
  ident: bib0175
  article-title: Rat testicular carboxylesterase: cloning sequencing, cellular localization and relationship to liver hydrolase A
  publication-title: Arch. Biochem. Biophys.
– volume: 84
  start-page: 232
  year: 2012
  end-page: 239
  ident: bib0160
  article-title: Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation
  publication-title: Biochem. Pharmacol.
– volume: 20
  start-page: 163
  year: 2006
  end-page: 175
  ident: bib0130
  article-title: Pharmacogenetics of irinotecan metabolism and transport: an update
  publication-title: Toxicol. In Vitro
– volume: 452
  start-page: 3
  year: 2013
  end-page: 7
  ident: bib0030
  article-title: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children
  publication-title: Int. J. Pharm.
– volume: 269
  start-page: 29688
  year: 1994
  end-page: 29696
  ident: bib0170
  article-title: Rat kidney carboxylesterase: cloning, sequencing, cellular localization and relationship to liver hydrolase B
  publication-title: J. Biol. Chem.
– volume: 283
  start-page: 9674
  year: 2008
  end-page: 9680
  ident: bib0150
  article-title: Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 992
  year: 2011
  ident: 10.1016/j.tox.2015.02.007_bib0015
  article-title: Part 3: pharmacogenetic variability in phase II anticancer drug metabolism
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2010-0260
– volume: 10
  start-page: 1955
  year: 2003
  ident: 10.1016/j.tox.2015.02.007_bib0050
  article-title: Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1 CYP2 and CYP3 families
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867033456855
– start-page: 165
  year: 2012
  ident: 10.1016/j.tox.2015.02.007_bib0180
  article-title: Hydrolytic enzymes
– volume: 14
  start-page: 55
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0115
  article-title: What is personalized medicine: sharpening a vague term based on a systematic literature review
  publication-title: BMC Med. Ethics
  doi: 10.1186/1472-6939-14-55
– volume: 4
  start-page: 12
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0045
  article-title: Pharmacogenomics of cytochrome P450 3A4: recent progress toward the missing heritability problem
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2013.00012
– volume: 158
  start-page: 186
  year: 1999
  ident: 10.1016/j.tox.2015.02.007_bib0055
  article-title: Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.1999.8693
– volume: 41
  start-page: 844
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0065
  article-title: RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.112.050211
– volume: 269
  start-page: 29688
  year: 1994
  ident: 10.1016/j.tox.2015.02.007_bib0170
  article-title: Rat kidney carboxylesterase: cloning, sequencing, cellular localization and relationship to liver hydrolase B
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)43935-X
– volume: 53
  start-page: 1199
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0145
  article-title: Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity
  publication-title: J. Clin. Pharmacol.
  doi: 10.1002/jcph.161
– volume: 283
  start-page: 9674
  year: 2008
  ident: 10.1016/j.tox.2015.02.007_bib0150
  article-title: Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M709382200
– volume: 42
  start-page: 1096
  year: 2012
  ident: 10.1016/j.tox.2015.02.007_bib0200
  article-title: Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues
  publication-title: Xenobiotica
  doi: 10.3109/00498254.2012.694493
– volume: 37
  start-page: 1819
  year: 2009
  ident: 10.1016/j.tox.2015.02.007_bib0215
  article-title: Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.109.028209
– volume: 16
  start-page: 1207
  year: 2009
  ident: 10.1016/j.tox.2015.02.007_bib0110
  article-title: Human carboxylesterases: an update on CES1, CES2 and CES3
  publication-title: Protein Pept. Lett.
  doi: 10.2174/092986609789071324
– volume: 34
  start-page: 389
  year: 2006
  ident: 10.1016/j.tox.2015.02.007_bib0005
  article-title: Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.105.007807
– volume: 77
  start-page: 238
  year: 2009
  ident: 10.1016/j.tox.2015.02.007_bib0190
  article-title: Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2008.10.005
– volume: 312
  start-page: 571
  year: 2005
  ident: 10.1016/j.tox.2015.02.007_bib0135
  article-title: Simultaneous substitution of phenylalaine-305 and aspartate-318 of rat PXR by the corresponding human residues abolishes the ability to transactivate the cytochrome P4503A23 promoter
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.104.074971
– volume: 41
  start-page: 2175
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0095
  article-title: RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.113.054635
– volume: 33
  start-page: 1603
  year: 2005
  ident: 10.1016/j.tox.2015.02.007_bib0020
  article-title: Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.105.005611
– volume: 8
  start-page: 2696
  year: 2002
  ident: 10.1016/j.tox.2015.02.007_bib0155
  article-title: Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells
  publication-title: Clin. Cancer Res.
– volume: 316
  start-page: 899
  year: 1995
  ident: 10.1016/j.tox.2015.02.007_bib0175
  article-title: Rat testicular carboxylesterase: cloning sequencing, cellular localization and relationship to liver hydrolase A
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.1995.1121
– volume: 315
  start-page: 514
  year: 1994
  ident: 10.1016/j.tox.2015.02.007_bib0070
  article-title: Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution and the effects of age sex and xenobiotic treatment of rats
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.1994.1532
– volume: 126
  start-page: 186
  year: 1994
  ident: 10.1016/j.tox.2015.02.007_bib0120
  article-title: Age-dependent differences in the susceptibility of rats to deltamethrin
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.1994.1106
– volume: 34
  start-page: 880
  year: 2006
  ident: 10.1016/j.tox.2015.02.007_bib0075
  article-title: The human intestinal cytochrome P450 pie
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.105.008672
– volume: 29
  start-page: 1548
  year: 2001
  ident: 10.1016/j.tox.2015.02.007_bib0090
  article-title: Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms
  publication-title: Drug Metab. Dispos.
– volume: 72
  start-page: 686
  year: 2007
  ident: 10.1016/j.tox.2015.02.007_bib0185
  article-title: Interleukin-6 suppresses the expression of carboxylesterases HCE1 and HCE2 through transcriptional repression
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.107.036889
– volume: 46
  start-page: 1319
  year: 1997
  ident: 10.1016/j.tox.2015.02.007_bib0010
  article-title: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients
  publication-title: Diabetes
  doi: 10.2337/diab.46.8.1319
– volume: 203
  start-page: 937
  year: 2011
  ident: 10.1016/j.tox.2015.02.007_bib0125
  article-title: Surge in expression of carboxylesterase-1 during the post-natal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiq145
– volume: 22
  start-page: 889
  year: 1994
  ident: 10.1016/j.tox.2015.02.007_bib0040
  article-title: Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl) phthalate a peroxisome proliferator
  publication-title: Drug Metab. Dispos.
  doi: 10.1016/S0090-9556(25)08432-6
– volume: 1771
  start-page: 915
  year: 2007
  ident: 10.1016/j.tox.2015.02.007_bib0220
  article-title: Peroxisome proliferator-activated receptor structures: ligand specificity: molecular switch and interactions with regulators
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2007.01.007
– volume: 452
  start-page: 3
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0030
  article-title: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2012.05.079
– volume: 84
  start-page: 232
  year: 2012
  ident: 10.1016/j.tox.2015.02.007_bib0160
  article-title: Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2012.04.002
– volume: 30
  start-page: 541
  year: 2002
  ident: 10.1016/j.tox.2015.02.007_bib0165
  article-title: Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.30.5.541
– volume: 10
  start-page: 214
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0085
  article-title: Translational genomics in cancer research: converting profiles into personalized cancer medicine
  publication-title: Cancer Biol. Med.
– volume: 165
  start-page: 109
  year: 2001
  ident: 10.1016/j.tox.2015.02.007_bib0100
  article-title: Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals
  publication-title: Toxicology
  doi: 10.1016/S0300-483X(01)00416-4
– volume: 8
  start-page: e82562
  year: 2013
  ident: 10.1016/j.tox.2015.02.007_bib0105
  article-title: Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0082562
– volume: 20
  start-page: 163
  year: 2006
  ident: 10.1016/j.tox.2015.02.007_bib0130
  article-title: Pharmacogenetics of irinotecan metabolism and transport: an update
  publication-title: Toxicol. In Vitro
  doi: 10.1016/j.tiv.2005.06.045
– volume: 409
  start-page: 243
  year: 2008
  ident: 10.1016/j.tox.2015.02.007_bib0060
  article-title: The far and distal enhancers in the CYP3A4 gene coordinates the proximal promoter in responding to the pregnane X receptor similarly but differentially to hepatocyte nuclear factor-4α
  publication-title: Biochem. J.
  doi: 10.1042/BJ20070613
– volume: 24
  start-page: 762
  year: 2004
  ident: 10.1016/j.tox.2015.02.007_bib0195
  article-title: Towards an understanding of organic anion transporters: structure-function relationships
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.20014
– volume: 51
  start-page: 75
  year: 2010
  ident: 10.1016/j.tox.2015.02.007_bib0140
  article-title: Normal canine pediatric gastrointestinal ultrasonography
  publication-title: Vet. Radiol. Ultrasound
  doi: 10.1111/j.1740-8261.2009.01626.x
– volume: 95
  start-page: 258
  year: 2014
  ident: 10.1016/j.tox.2015.02.007_bib0205
  article-title: Genetics: epigenetics and regulation of drug metabolizing cytochrome P450 enzymes
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1038/clpt.2013.220
– volume: 11
  start-page: 206
  year: 2010
  ident: 10.1016/j.tox.2015.02.007_bib0035
  article-title: Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2010.02.001
– volume: 28
  start-page: 186
  year: 2000
  ident: 10.1016/j.tox.2015.02.007_bib0210
  article-title: Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats
  publication-title: Drug Metab. Dispos.
  doi: 10.1016/S0090-9556(24)15127-6
– volume: 39
  start-page: 565
  year: 2011
  ident: 10.1016/j.tox.2015.02.007_bib0025
  article-title: The intestine as an important contributor to prasugrel active metabolite formation in vivo
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.110.035956
– volume: 37
  start-page: 2112
  year: 2009
  ident: 10.1016/j.tox.2015.02.007_bib0080
  article-title: MicroRNAs regulate CYP3A4 expression via direct and indirect targeting
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.109.027680
– reference: 11522369 - Toxicology. 2001 Aug 28;165(2-3):109-19
– reference: 7864649 - Arch Biochem Biophys. 1995 Feb 1;316(2):899-908
– reference: 7986099 - Arch Biochem Biophys. 1994 Dec;315(2):513-26
– reference: 12171903 - Clin Cancer Res. 2002 Aug;8(8):2696-700
– reference: 7961958 - J Biol Chem. 1994 Nov 25;269(47):29688-96
– reference: 23939663 - J Clin Pharmacol. 2013 Nov;53(11):1199-204
– reference: 16467132 - Drug Metab Dispos. 2006 May;34(5):880-6
– reference: 21189331 - Drug Metab Dispos. 2011 Apr;39(4):565-70
– reference: 8184428 - Toxicol Appl Pharmacol. 1994 May;126(1):186-90
– reference: 16049125 - Drug Metab Dispos. 2005 Nov;33(11):1603-7
– reference: 16271446 - Toxicol In Vitro. 2006 Mar;20(2):163-75
– reference: 24196843 - Clin Pharmacol Ther. 2014 Mar;95(3):258-61
– reference: 9231657 - Diabetes. 1997 Aug;46(8):1319-27
– reference: 18268015 - J Biol Chem. 2008 Apr 11;283(15):9674-80
– reference: 22766445 - Int J Pharm. 2013 Aug 16;452(1-2):3-7
– reference: 23382457 - Drug Metab Dispos. 2013 Apr;41(4):844-57
– reference: 11717173 - Drug Metab Dispos. 2001 Dec;29(12):1548-54
– reference: 15250040 - Med Res Rev. 2004 Nov;24(6):762-74
– reference: 22513142 - Biochem Pharmacol. 2012 Jul 15;84(2):232-9
– reference: 20166399 - Vet Radiol Ultrasound. 2010 Jan-Feb;51(1):75-8
– reference: 17764444 - Biochem J. 2008 Jan 1;409(1):243-50
– reference: 19487248 - Drug Metab Dispos. 2009 Sep;37(9):1819-25
– reference: 17317294 - Biochim Biophys Acta. 2007 Aug;1771(8):915-25
– reference: 23444277 - Front Genet. 2013 Feb 25;4:12
– reference: 12871098 - Curr Med Chem. 2003 Oct;10(19):1955-72
– reference: 18983829 - Biochem Pharmacol. 2009 Jan 15;77(2):238-47
– reference: 24340040 - PLoS One. 2013;8(12):e82562
– reference: 10640517 - Drug Metab Dispos. 2000 Feb;28(2):186-91
– reference: 22694178 - Xenobiotica. 2012 Nov;42(11):1096-109
– reference: 11950785 - Drug Metab Dispos. 2002 May;30(5):541-7
– reference: 19508181 - Protein Pept Lett. 2009;16(10):1207-14
– reference: 1714639 - Toxicology. 1991;68(1):51-61
– reference: 24359531 - BMC Med Ethics. 2013;14:55
– reference: 7895606 - Drug Metab Dispos. 1994 Nov-Dec;22(6):889-94
– reference: 19581388 - Drug Metab Dispos. 2009 Oct;37(10):2112-7
– reference: 20197053 - Cell Metab. 2010 Mar 3;11(3):206-12
– reference: 21659608 - Oncologist. 2011;16(7):992-1005
– reference: 17537833 - Mol Pharmacol. 2007 Sep;72(3):686-94
– reference: 15367577 - J Pharmacol Exp Ther. 2005 Feb;312(2):571-82
– reference: 21402544 - J Infect Dis. 2011 Apr 1;203(7):937-42
– reference: 24349831 - Cancer Biol Med. 2013 Dec;10(4):214-20
– reference: 16326812 - Drug Metab Dispos. 2006 Mar;34(3):389-97
– reference: 10406933 - Toxicol Appl Pharmacol. 1999 Jul 15;158(2):186-96
– reference: 24080161 - Drug Metab Dispos. 2013 Dec;41(12):2175-86
SSID ssj0002346
Score 2.3066955
Snippet Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and oxidative...
Abstract Human carboxylesterase-2 (CES2) and cytochrome P450 3A4 (CYP3A4) are two major drug metabolizing enzymes that play critical roles in hydrolytic and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 55
SubjectTerms Adult
adults
Age
Amino Acid Sequence
biotransformation
Carboxylesterase - biosynthesis
Carboxylesterase - genetics
Carboxylesterases
Control
cytochrome P-450
Cytochrome P-450 CYP3A - biosynthesis
Cytochrome P-450 CYP3A - genetics
Cytochrome P450
Cytochromes P450
Drug metabolism
Drugs
duodenum
Duodenum - enzymology
Duodenum - growth & development
Emergency
enzymes
Female
Gene expression
Gene Expression Regulation, Enzymologic
genes
Human
Humans
Infant, Newborn
jejunum
Liver
Liver - enzymology
Liver - growth & development
Male
messenger RNA
metabolism
Molecular Sequence Data
Ontogeny
Surges
therapeutics
tissues
Toxicology
Young Adult
Title Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0300483X15000438
https://www.clinicalkey.es/playcontent/1-s2.0-S0300483X15000438
https://dx.doi.org/10.1016/j.tox.2015.02.007
https://www.ncbi.nlm.nih.gov/pubmed/25724353
https://www.proquest.com/docview/1664192066
https://www.proquest.com/docview/1732832022
https://www.proquest.com/docview/1770317964
https://www.proquest.com/docview/1846311648
Volume 330
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe27gUJIRhf5WMyEtoDWqhjO07DWzUxFSpGBZvom2UnDhRVydSkUvvCn8DfzPkjnRCsSDxFSc7Kx13uLvbvfofQy6IoUmVKHpWF0BHnXEcKDCXSxpjY8KQcOrqmD-difMnfz5LZHjrtamEsrDL4fu_TnbcORwbhbQ6u5vPBZ8IcH_osTvx61j46oCwTSQ8djN5Nxudbh0xZqNchxM6dzbrFTQfzauu1BXglnrkzvSk83ZR-ujB0dhfdCfkjHvlbvIf2THWIjqeegHpzgi-u66maE3yMp9fU1JtDdNvP0mFffHQf_fxYtTWYEBwy6wCJrXBdYte6D-dqqev1ZuHYFCDcRRSrqsD5pq3zb5bnAE95QjAbcTyv8MJCPJxAsaoLC7F_g20v4MrOEOHG1l-7s66RVNR1323x0nwNPcQeoMuztxen4yh0aIhy-O1pQTRmiShjxomiJQG9F6JkSsdEU0UyldFExynTOWecaqZMPMzTkuki05BqmJQ9RL2qrsxjhCHvo0wLxpjF3Imh1iJTJVEJ2E9amryPSKcYmQf6cttFYyE7nNp3CbqUVpeSUAm67KNX2yFXnrtjlzDttC27olRwoxIiy65B6d8GmSY4gkbGsgFJ-Yex9hHfjvzN3v91wRedIUrwA3ZxR1WmXsGFhLAL-pBB7pCxzEyMQtq2S8Z2NLAFyjtkIGllMfxow2M88l_D9gVDCKCQgrMn__eAT9Etu-exUc9Qr12uzHNI-1p9hPZf_4iPwsdtt5NPXya_AC-WWWQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdd-rBBGVv30exTg9GHURNZku1kb6GspGubBZZC3oRkS1tGsEvsQPJP7G_e6cMpY2sGe7VP2Nad707S736H0PuiKDKpDY9MkaqIc64iCYYSKa11rHli-o6u6Wqcjq7551ky20OnbS2MhVUG3-99uvPW4UovzGbvZj7vfSXM8aHP4sSfZ91D-zyB1V4H7Q_PL0bjrUOmLNTrEGL3zmbt4aaDeTXV2gK8Es_cmd0Vnu5KP10YOnuEHob8EQ_9Kz5Ge7o8RMcTT0C9OcHT23qq-gQf48ktNfXmEB34XTrsi4-eoJ9fyqYCE4JLeh0gsSWuDHat-3Aul6pabxaOTQHCXUSxLAucb5oq_255DvCEJwSzIcfzEi8sxMMJFKuqsBD7j9j2Ai7tDhGubf21u-saSUVt990GL_W30EPsKbo--zQ9HUWhQ0OUw7KnAdGYJamJGSeSGgJ6L1LDpIqJopIM5IAmKs6YyjnjVDGp436eGaaKgYJUQ2fsGeqUVamPEIa8jzKVMsYs5i7tK5UOpCEyAfvJjM67iLSKEXmgL7ddNBaixan9EKBLYXUpCBWgyy76sB1y47k7dgnTVtuiLUoFNyogsuwalP1tkK6DI6hFLGqQFH8Yaxfx7cjf7P1fD3zXGqIAP2APd2SpqxU8KE3tgT5kkDtkLDMTo5C27ZKxHQ1sgfIOGUhaWQwLbfiM5_5v2E4whAAKKTh78X8f-BbdH02vLsXl-fjiJXpg73ic1CvUaZYr_RpSwEa9Cb_4L59WWbA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ontogenic+expression+of+human+carboxylesterase-2+and+cytochrome+P450+3A4+in+liver+and+duodenum%3A+Postnatal+surge+and+organ-dependent+regulation&rft.jtitle=Toxicology+%28Amsterdam%29&rft.au=Chen%2C+Yi-Tzai&rft.au=Trzoss%2C+Lynnie&rft.au=Yang%2C+Dongfang&rft.au=Yan%2C+Bingfang&rft.date=2015-04-01&rft.issn=0300-483X&rft.volume=330+p.55-61&rft.spage=55&rft.epage=61&rft_id=info:doi/10.1016%2Fj.tox.2015.02.007&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0300483X%2FS0300483X15X00035%2Fcov150h.gif